Source:http://linkedlifedata.com/resource/pubmed/id/21048024
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
2011-1-7
|
pubmed:abstractText |
Multipotent mesenchymal stem cells (MSC) have become a popular and promising therapeutic approach in many clinical conditions. MSC are beneficial in animal models of acute kidney injury (AKI), by mediating differentiation-independent paracrine properties, and have prompted ongoing clinical trials to evaluate the safety and efficacy of MSC. Heme oxygenase-1 (HO-1) is induced in response to stress including AKI and has important anti-apoptotic, anti-inflammatory, and proangiogenic properties in these settings. We therefore examined whether HO-1 plays a role in the beneficial effects of MSC in AKI. We isolated MSC from bone marrow of age-matched HO-1+/+ and HO-1-/- mice. Our studies indicate that while differentiation of MSC into osteo- and adipocytic lineages did not differ between cells isolated from HO-1+/+ and HO-1-/- mice, MSC from HO-1-/- mice had significantly lower angiogenic potential. Moreover, HO-1-/- MSC demonstrated reduced expression and secretion of several important growth and proangiogenic factors (stromal cell-derived factor-1, vascular endothelial growth factor-A, and hepatocyte growth factor) compared with MSC derived from HO-1+/+ mice. In addition, conditioned medium of HO-1+/+ MSC rescued functional and morphological changes associated with cisplatin-induced AKI, while the HO-1-/--conditioned medium was ineffectual. Our studies indicate that HO-1 plays an important role in MSC-mediated protection. The results expand understanding of the renoprotective effects of MSC and may provide novel strategies to better utilize MSC in various disease models.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Chemokine CXCL12,
http://linkedlifedata.com/resource/pubmed/chemical/Cisplatin,
http://linkedlifedata.com/resource/pubmed/chemical/Culture Media, Conditioned,
http://linkedlifedata.com/resource/pubmed/chemical/Cxcl12 protein, mouse,
http://linkedlifedata.com/resource/pubmed/chemical/HGF protein, mouse,
http://linkedlifedata.com/resource/pubmed/chemical/Heme Oxygenase-1,
http://linkedlifedata.com/resource/pubmed/chemical/Hepatocyte Growth Factor,
http://linkedlifedata.com/resource/pubmed/chemical/Vascular Endothelial Growth Factor A,
http://linkedlifedata.com/resource/pubmed/chemical/vascular endothelial growth factor...
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
1522-1466
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
300
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
F254-62
|
pubmed:dateRevised |
2011-5-9
|
pubmed:meshHeading |
pubmed-meshheading:21048024-Acute Kidney Injury,
pubmed-meshheading:21048024-Animals,
pubmed-meshheading:21048024-Anoxia,
pubmed-meshheading:21048024-Chemokine CXCL12,
pubmed-meshheading:21048024-Cisplatin,
pubmed-meshheading:21048024-Culture Media, Conditioned,
pubmed-meshheading:21048024-Heme Oxygenase-1,
pubmed-meshheading:21048024-Hepatocyte Growth Factor,
pubmed-meshheading:21048024-Male,
pubmed-meshheading:21048024-Mesenchymal Stem Cells,
pubmed-meshheading:21048024-Mice,
pubmed-meshheading:21048024-Multipotent Stem Cells,
pubmed-meshheading:21048024-Neovascularization, Physiologic,
pubmed-meshheading:21048024-Paracrine Communication,
pubmed-meshheading:21048024-Vascular Endothelial Growth Factor A
|
pubmed:year |
2011
|
pubmed:articleTitle |
Paracrine effects of mesenchymal stem cells in cisplatin-induced renal injury require heme oxygenase-1.
|
pubmed:affiliation |
Department of Medicine, Nephrology Research Training Center, University of Alabama at Birmingham, 1900 Univ. Blvd., Birmingham, Alabama 35294, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, N.I.H., Extramural
|